Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03824652 · ClinicalTrials.gov registry record · Phase 2

WALNUTS for POWER: Polyphenols, Omega-3 Fatty Acids, Weight Loss, and EneRgy

A Phase 2 study of Prostate Cancer, sponsored by Stephen Freedland.

Recruiting
Registry status
Phase 2
Development phase
50
Enrollment target
2
Study locations

NCT03824652: Recruiting Phase 2 study of Prostate Cancer, sponsored by Stephen Freedland.

NCT03824652 is a Phase 2 study of Prostate Cancer that is actively recruiting participants, run by Stephen Freedland. The registered enrollment target is 50 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03824652, a Phase 2 study of Prostate Cancer, is actively recruiting participants, sponsored by Stephen Freedland.

RECRUITING
Registry status
Phase 2
Development phase
50 participants
Enrollment target
2
Study locations

Study Summary

This is a randomized control trial testing the effect of walnut supplementation on prostate cancer progression in 50 men with biopsy confirmed prostate cancer and planning to undergo RP. Patients consented to the study will be randomly assigned to either continue their usual diets (control arm) or to the walnut arm for 4-10 weeks depending on the window between their consent date and the date for RP.

Conditions Studied

Prostate Cancer

Interventions

  • OTHER walnuts
  • OTHER usual diet
  • OTHER phone counseling with dietitian

Study Locations (2)

California

  • Cedars-Sinai Medical Center - Los Angeles

North Carolina

  • Durham VA Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2019-04-22
Est. Completion 2027-06
Phase Phase 2

Sponsor

Stephen Freedland

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03824652

The ClinicalTrials.gov registry entry for NCT03824652 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (92% lower). The listed sponsor is Stephen Freedland, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 3 interventions - of which walnuts is the first listed.

NCT03824652 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, North Carolina.

Frequently Asked Questions

What is clinical trial NCT03824652 about?

NCT03824652 is a clinical study titled "WALNUTS for POWER: Polyphenols, Omega-3 Fatty Acids, Weight Loss, and EneRgy". This is a randomized control trial testing the effect of walnut supplementation on prostate cancer progression in 50 men with biopsy confirmed prostate cancer and planning to undergo RP. Patients consented to the study will be randomly assigned to either continue their usual diets (control arm) or t...

What is the current status of trial NCT03824652?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2019-04-22. Estimated completion is 2027-06.

What conditions does trial NCT03824652 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT03824652?

The interventions under investigation include: walnuts (OTHER), usual diet (OTHER), phone counseling with dietitian (OTHER).

Who is sponsoring clinical trial NCT03824652?

This trial is sponsored by Stephen Freedland, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03824652 being conducted?

This trial has 2 study locations across California, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.